Literature DB >> 32603429

Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.

Yukiko Fu1,2, Kentaro Kaneko1, Hsiao-Yun Lin1, Qianxing Mo3, Yong Xu1,4, Takayoshi Suganami2, Peter Ravn5, Makoto Fukuda1.   

Abstract

The hypothalamus plays a critical role in controlling energy balance. High-fat diet (HFD) feeding increases the gene expression of proinflammatory mediators and decreases insulin actions in the hypothalamus. Here, we show that a gut-derived hormone, glucose-dependent insulinotropic polypeptide (GIP), whose levels are elevated during diet-induced obesity, promotes and mediates hypothalamic inflammation and insulin resistance during HFD-induced obesity. Unbiased ribonucleic acid sequencing of GIP-stimulated hypothalami revealed that hypothalamic pathways most affected by intracerebroventricular (ICV) GIP stimulation were related to inflammatory-related responses. Subsequent analysis demonstrated that GIP administered either peripherally or centrally, increased proinflammatory-related factors such as Il-6 and Socs3 in the hypothalamus, but not in the cortex of C57BL/6J male mice. Consistently, hypothalamic activation of IκB kinase-β inflammatory signaling was induced by ICV GIP. Further, hypothalamic levels of proinflammatory cytokines and Socs3 were significantly reduced by an antagonistic GIP receptor (GIPR) antibody and by GIPR deficiency. Additionally, centrally administered GIP reduced anorectic actions of insulin in the brain and diminished insulin-induced phosphorylation of Protein kinase B and Glycogen synthase kinase 3β in the hypothalamus. Collectively, these findings reveal a previously unrecognized role for brain GIP signaling in diet-induced inflammation and insulin resistance in the hypothalamus. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  G protein-coupled receptors; glucose-dependent insulinotropic polypeptide (GIP); hypothalamus; inflammation; obesity; peptides

Mesh:

Substances:

Year:  2020        PMID: 32603429      PMCID: PMC7410368          DOI: 10.1210/endocr/bqaa102

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  85 in total

Review 1.  Hypothalamic inflammation in obesity and metabolic disease.

Authors:  Alexander Jais; Jens C Brüning
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.

Authors:  Brian Finan; Tao Ma; Nickki Ottaway; Timo D Müller; Kirk M Habegger; Kristy M Heppner; Henriette Kirchner; Jenna Holland; Jazzminn Hembree; Christine Raver; Sarah H Lockie; David L Smiley; Vasily Gelfanov; Bin Yang; Susanna Hofmann; Dennis Bruemmer; Daniel J Drucker; Paul T Pfluger; Diego Perez-Tilve; Jaswant Gidda; Louis Vignati; Lianshan Zhang; Jonathan B Hauptman; Michele Lau; Mathieu Brecheisen; Sabine Uhles; William Riboulet; Emmanuelle Hainaut; Elena Sebokova; Karin Conde-Knape; Anish Konkar; Richard D DiMarchi; Matthias H Tschöp
Journal:  Sci Transl Med       Date:  2013-10-30       Impact factor: 17.956

Review 3.  SOCS3 as a future target to treat metabolic disorders.

Authors:  João A B Pedroso; Angela M Ramos-Lobo; Jose Donato
Journal:  Hormones (Athens)       Date:  2018-11-09       Impact factor: 2.885

4.  Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice.

Authors:  Dai Chida; Toshimasa Osaka; Okito Hashimoto; Yoichiro Iwakura
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

Review 5.  Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease.

Authors:  Christian Holscher
Journal:  Recent Pat CNS Drug Discov       Date:  2010-06

6.  Neuronal Rap1 Regulates Energy Balance, Glucose Homeostasis, and Leptin Actions.

Authors:  Kentaro Kaneko; Pingwen Xu; Elizabeth L Cordonier; Siyu S Chen; Amy Ng; Yong Xu; Alexei Morozov; Makoto Fukuda
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

7.  The effect of energy source and feeding level on the hormones of the entero-insular axis and plasma glucose in the growing pig.

Authors:  A A Ponter; D N Salter; L M Morgan; P R Flatt
Journal:  Br J Nutr       Date:  1991-09       Impact factor: 3.718

8.  Gipr is essential for adrenocortical steroidogenesis; however, corticosterone deficiency does not mediate the favorable metabolic phenotype of Gipr(-/-) mice.

Authors:  Holly E Bates; Jonathan E Campbell; John R Ussher; Laurie L Baggio; Adriano Maida; Yutaka Seino; Daniel J Drucker
Journal:  Diabetes       Date:  2011-10-31       Impact factor: 9.461

Review 9.  Hypothalamic inflammation: marker or mechanism of obesity pathogenesis?

Authors:  Joshua P Thaler; Stephan J Guyenet; Mauricio D Dorfman; Brent E Wisse; Michael W Schwartz
Journal:  Diabetes       Date:  2013-08       Impact factor: 9.461

10.  LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.

Authors:  Tamer Coskun; Kyle W Sloop; Corina Loghin; Jorge Alsina-Fernandez; Shweta Urva; Krister B Bokvist; Xuewei Cui; Daniel A Briere; Over Cabrera; William C Roell; Uma Kuchibhotla; Julie S Moyers; Charles T Benson; Ruth E Gimeno; David A D'Alessio; Axel Haupt
Journal:  Mol Metab       Date:  2018-10-03       Impact factor: 7.422

View more
  7 in total

1.  Phoenixin-14 alters transcriptome and steroid profiles in female green-spotted puffer (Dichotomyctere nigroviridis).

Authors:  Timothy S Breton; Casey A Murray; Sierra R Huff; Anyssa M Phaneuf; Bethany M Tripp; Sarah J Patuel; Christopher J Martyniuk; Matthew A DiMaggio
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

2.  An orally active plant Rubisco-derived peptide increases neuronal leptin responsiveness.

Authors:  Kentaro Kaneko; Yukihiro Takekuma; Tsuyoshi Goto; Kousaku Ohinata
Journal:  Sci Rep       Date:  2022-05-21       Impact factor: 4.996

Review 3.  Central Neurocircuits Regulating Food Intake in Response to Gut Inputs-Preclinical Evidence.

Authors:  Kirsteen N Browning; Kaitlin E Carson
Journal:  Nutrients       Date:  2021-03-11       Impact factor: 5.717

Review 4.  Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms.

Authors:  Jonathan E Campbell
Journal:  Mol Metab       Date:  2020-12-05       Impact factor: 7.422

5.  Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer's Disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Jan Homolak; Ana Babic Perhoc; Melita Salkovic-Petrisic
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

6.  Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes.

Authors:  Tauqeerunnisa Syeda; Mónica Sánchez-Tapia; Itzel Orta; Omar Granados-Portillo; Lizbeth Pérez-Jimenez; Juan-de-Dios Rodríguez-Callejas; Samuel Toribio; Maria-Del-Carmen Silva-Lucero; Ana-Leonor Rivera; Armando R Tovar; Nimbe Torres; Claudia Perez-Cruz
Journal:  Nutrients       Date:  2021-12-22       Impact factor: 5.717

7.  Ultrasound targeted microbubble destruction-mediated SOCS3 attenuates biological characteristics and epithelial-mesenchymal transition (EMT) of breast cancer stem cells.

Authors:  Xiaojiang Tang; Na Hao; Yuhui Zhou; Yang Liu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.